Abstract
The inflammatory myocardial disease, commonly called inflammatory cardiomyopathy, has become a challenging part of cardiology. The development in the treatment of this disease is based on new diagnostic methods, such as magnetic resonance or endomyocardial biopsy including the immunohistochemical staining and molecular techniques for viral diagnostics.
Except conventional treatment we have some new potentially beneficial treatment strategies.